Perbedaan Budi Starch Sweetener Tbk dan Brigit Biofarmaka Teknologi Tbk.: Budi Starch Sweetener Tbk diperdagangkan di Rp206 (kapitalisasi pasar 926,79 M, volume 24 jam 36,6 rb), sedangkan Brigit Biofarmaka Teknologi Tbk. diperdagangkan di Rp248 (kapitalisasi pasar 167,37 M, volume 24 jam 96,7 rb). Perbedaan utamanya: Budi Starch Sweetener Tbk jauh lebih besar — sekitar 5,5× kapitalisasi pasar Brigit Biofarmaka Teknologi Tbk., dan Brigit Biofarmaka Teknologi Tbk. lebih aktif diperdagangkan (96,7 rb vs 36,6 rb). Mana yang lebih baik tergantung tujuan investasimu.
| BUDI | OBAT | |
|---|---|---|
Kapitalisasi Pasar | 926,79 M | 167,37 M |
Volume | 36,6 rb | 96,7 rb |
Lot | 366 | 967 |
Perputaran | 7,54 jt | 23,82 jt |
Harga Rata-rata | 206 | 246,34 |
Nilai Transaksi | 7,54 jt | 23,82 jt |
Harga Ekuilibrium Indikatif | 206 | 248 |
Volume Ekuilibrium Indikatif | 46 | 41 |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
PT Budi Starch & Sweetener Tbk (the Company) formerly Budi Acid Jaya (BAJ) was established based on Notarial Deed No. 15 dated January 15, 1979 of Henk Limanow, SH., public notary in Jakarta. PT Budi Starch & Sweetener Tbk is the world`s largest tapioca starch producer. BAJ is an integrated cassava based manufacturer : citric acid, modified tapioca starch and monosodium glutamate (MSG). It also produces sulphuric acid and poly propelene woven bag.
Selengkapnya di halaman BUDI →PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Selengkapnya di halaman OBAT →